Hamed I. Ali

Advances in the design and discovery of small-molecule tyrosine kinase inhibitors for breast cancer

These efforts underscore the importance of integrating scaffolds from promising candidate and clinically approved drugs to advance next-generation kinase inhibitors targeting breast cancer subtypes, thereby overcoming challenges and improving structural optimization outcomes.